February 18, 2025 · Form 4 insider transaction
Biller Jonathan sold 1,657 shares of Vertex Pharmaceuticals Incorporated at $455.06 per share, a transaction worth $754.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024.